Dr. Vegard Skirbekk
University of Oslo
What are one or two data points or findings about men’s health that you think readers will find surprising or counterintuitive?
One surprising finding is that the female-male life expectancy gap can narrow dramatically — or even nearly disappear — in certain settings, challenging the idea that it’s purely biological and inevitable. Through our ERC-funded HOMME project, which I lead, we’re identifying specific communities and contexts where men not only survive but thrive with long lives close to matching female life expectancy. We also need to understand why the inequality among men is so high and much higher than among women.
Men die younger than women in almost every country, yet the social, commercial, and structural factors behind this gap are still not well understood or sufficiently addressed. Why has the field been slow to apply a gendered lens to men’s health, and what are we missing as a result?
The field equated “gender” with “women” for historical reasons of gender discrimination. Some political activists may view men as the privileged default who didn’t need attention. There is insufficient focus on male health, as gender-focused discussions on health commonly focus on women, and particularly issues related to reproduction. We know that men have shorter lives. We do not know, even if it is commonly suggested, that men have better health. Men are using health services to a much lower degree, and men participate far less in health surveys — particularly those with low socioeconomic status. As a result, we’re missing opportunities to understand and address how social norms, economic pressures, and structural factors shape male behaviours. The key is finding better ways to channel typical male behaviours and risk-taking into productive rather than self-destructive directions.
For decades, “gender and health” has effectively meant reproductive health for women aged 15–49. What does it cost us to keep operating with that frame?
Male health issues have always existed, but achieving greater equity in life expectancy has rarely been a priority in policymaking. Continuing with a narrow frame costs us lost years of life, higher societal burdens from premature male mortality, and missed opportunities for holistic gender-responsive policies that benefit entire populations. Men’s excess mortality is overwhelmingly behavioural, social and commercial rather than biological: risk-taking, low help-seeking shaped by masculinity norms, occupational hazards, and industries — tobacco, alcohol, gambling, ultra-processed food — that disproportionately target men.
Men’s Health Week is a valuable opportunity to spotlight neglected issues — but it can also inadvertently reinforce the idea that men’s and women’s health are competing priorities. How do we use moments like this to advance a gender approach that works for everyone, without that becoming cover for shifting resources and attention away from women?
Aligning male-female mortality more closely would deliver huge benefits for all, perhaps particularly women. More men alive means fewer brotherless, sonless, partner-less and fatherless women. This would represent an important social, economic, practical and emotional gain. We should see it as a win-win: closing the mortality gap would deliver benefits for families and communities that flow especially to women. A truly gender-responsive approach strengthens outcomes for everyone without pitting groups against each other.
Social factors like income, education, and isolation appear to drive much of the variation in men’s health outcomes across countries. What does that tell us about where interventions should be targeted, and what would gender-responsive interventions actually look like?
This variation shows that interventions should target social determinants — particularly in lower-income or isolated communities where risks are highest. Gender-responsive interventions would identify and scale up communities and settings where men thrive: places that support productive, meaningful, long lives through positive social roles, reduced isolation, better education and employment pathways, and environments that align with male strengths and behaviours. We should use gender-specific approaches that meet men where they are — workplaces, sports clubs, online — rather than waiting for them to show up at a clinic.
The manosphere preys on real, measurable disadvantages in men’s health and wellbeing, including social isolation, poor mental health outcomes and economic marginalisation. Why has public health been so slow to respond to this — and do you think the manosphere should be treated as a public health issue?
Public health has been slow because it often fails to engage men where they are — academia and official messaging rarely reach those most in need. The manosphere fills this vacuum by addressing real disadvantages (isolation, mental health, economic marginalisation), but often with harmful framing. Yes, it should be treated as a public health issue. We need to popularise evidence-based approaches that actually benefit men: channelling risk-taking productively, while promoting positive masculine ideals. Very few men read academic papers; effective solutions must be freely accessible, instantly available, resonant, and action-oriented.
